On June 13, 2018, Mr. Axel Bolte, a director of Nabriva Therapeutics plc, notified the company of his decision not to stand for re-election to the company’s board of directors at the 2018 Annual General Meeting of Shareholders. Mr. Bolte is expected to continue his service on the board of directors of the Company until the expiration of his term at the Annual Meeting on August 1, 2018.